TrialInternational journal of hematology2026

Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.

Tadaaki Inano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.